RiboTargets Ltd. 's investors got the biggest haircut, but British Biotech PLC , the scandal-tarnished one-time flagship of the UK's biotechnology industry, has emerged from a proposed £26 million ($40.7 million) merger with the brand-new look [See Deal].
Now British Biotech—which is also in the process of changing its name—will boast a new research platform, a new CEO...